Here are the last years publications to FORENAP expertise fields. For any information related to the subjects of these publications, please do not hesitate to contact us.
- Grenèche J, Krieger J, Erhardt C, Bonnefond A, Eschenlauer A, Muzet A, Tassi P. EEG spectral power and sleepiness during 24 h of sustained wakefulness in patients with obstructive sleep apnea syndrome. Clin Neurophysiol 2008 ;119 :418-428.
- Grenèche J, Sarémi M, Erhardt C, Hoeft A, Eschenlauer A, Muzet A, Tassi P. Severity of obstructive sleep apnoea/hypopnoea syndrome and subsequent waking EEG spectral power. Eur Respir J 2008;32:705-709.
- Otmani S, Demazières A, Staner C, Jacob N, Nir T, Zisapel N, Staner L. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol Clin Exp 2008 (in press).
- Rogé J, Otmani S, Pébayle T, Muzet A. The impact of age on useful visual field deterioration and risk evaluation in a simulated driving task. Eur Rev Appl Psychol 2008 ;58 :5-12.
- Saremi M, Rohmer O, Burgmeier A, Bonnefond A, Muzet A, Tassi P. Combined effects of noise and shiftwork on fatigue as a function of age. International Journal of Occupational Safety and Ergonomics (in press).
- Schunck T, Erb G, Mathis A, Jacob N, Gilles C, Namer IJ, Meier D, Luthringer R. Test-retest reliability of a functional MRI anticipatory anxiety paradigm in healthy volunteers. J Magn Reson Imaging 2008;27:459-468.
- Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study. Sleep Medicine (In Press).
- Tassi P, Grenèche J, Pebayle T, Eschenlauer A, Hoeft A, Bonnefond A, Rohmer O, Muzet A. Are OSAS patients impaired in their driving ability on a circuit with medium traffic density? Accident Analysis and Prevention 2008;40:1365–1370.
- Tohmé M, Lengellé R. F-SVR: a new learning algorithm for support vector regression. Proceedings of IEEE International Conference on Acoustics, Speech ans Signal Processing 2008 :2005-8.
- Boeijinga PH, Soufflet L, Santoro F, Luthringer R. Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man. J Psychopharmacol 2007;21(3):321-337.
- Deacon S, Staner L, Staner C, Legters A, Loft H, Lundahl J. Effect of short-term treatment with gaboxadol on sleep maintenance and initiation in patients with primary insomnia. Sleep 2007;30(3):281-287.
- Dunbar G, Boeijinga PH, Demazières A, Cisterni C, Kuchibhatla R, Wesnes K, Luthringer R. Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers. Psychopharmacology 2007;191(4):919-929.
- Gilles C, Luthringer R. Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs. J Psychopharmacol 2007;21(3):272-282.
- Lundahl J, Staner L, Staner C, Loft H, Deacon S. Short treatment with Gaboxadol improves sleep maintenace and enhances slow wave sleep in adult patients with primary insomnia. Psychopharmacology 2007;195:139-146.
- Luthringer R, Staner L, Noel N, Muzet M, Gassmann-Mayer C, Talluri K, Cleton A, Eerdekens M, Battisti WP, Palumbo JM. A double-blind, placebo-controlled, randomized study evaluating the effect of paliperidone extended release tablets on sleep architecture in patients with schizophrenia. Int Clin Psychopharmacol 2007 ; 22(5):299-308.
- Morain P, Boeijinga P, Demazières A, De Nanteuil G, Luthringer R. Psychotropic profile of S 17092, a prolyl-endopeptidase inhibitor, using quantitative EEG in young healthy volunteers. Neuropsychobiology 2007;55:176-183.
- Muzet A. Environmental noise, sleep and health. Sleep Medicine Reviews 2007;11:135-142.
- Aubin HJ, Luthringer R, Demazières A, Dupont C, Lagrue G. Comparison of the effects of a 24-hour nicotine patch and a 16-hour nicotine patch on smoking urges and sleep. Nic Tob Res 2006; 8(2):193-201.
- Cerf R. Catastrophe theory enables moves to be detected towards and away from self-organization: the example of epileptic seizure onset. Biol Cybernetics 2006; 94(6):459-68.
- Constantin I, Richard C, Lengellé R, Soufflet L. Nonlinear regularized wiener filtering with kernel : application in denoising MEG data corrupted by ECG. IEEE Trans Signal Process 2006 ;54(12):4796-4806.
- Demazieres A, Luthringer R, Coppel E, Gilles C, Fleury C, Roegel JC, Delarue A, Laur C, Lagrue G. Ability of a new oral nicotine substitute to reduce smoking urge in moderate smokers. Addict Behav 2006, 31(3):537-43.
- Dunbar G, Demazières A, Monreal A, Cisterni C, Metzger D, Kuchibhatla R, Luthringer R. Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers. J Clin Pharmacol 2006;46(7):715-726.
- Muzet A.. Bruit et sommeil: répercussions sur la santé. Medecine/Sciences, 2006;22: 973-977.
- Pitchot W, Zouery D, Staner L, Zdanowicz N, Floris M. Système dopaminergique, dépression et antidépresseur. Acta Psychiatrica Belgica 2006, 106:5-13.
- Schunck T, Erb G, Mathis A, Gilles C, Namer IJ, Hode Y, Demazieres A, Luthringer R. Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety. Neuroimage 2006; 31(3):1197-208.
- Staner L, Boeijinga PH, Danel T, Gendre I, Muzet M, Landron F, Luthringer R. Effects of acamprosate on sleep during alcohol-withdrawal : a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res 2006 ;30 :1492-1499.
- Staner L, Luthringer R, Dupont C, Aubin HJ, Lagrue G. Sleep effects of a 24-hour versus a 16-hour nicotine patch: a polysomnographic study during smoking cessation. Sleep med 2006, 7:147-54.
- Staner L. Surrogate outcomes in neurology, psychiatry, and psychopharmacology. Dialogues in Neurosciences 2006;8(3):345-352.
- Chalon S, Pereira A, Lainey E et al. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects. Psychopharmacology (Berl) 2005; 177(4):357-65.
- Floris M, Pitchot W, Souery D, Staner L, Zdanowicz N. Schizophrenia, sleep and antipsychotics. Acta Psychiatrica Belgica 2005 ;105 :195-203.
- Haba-Rubio J, Staner L, Krieger J, Macher JP. Periodic limb movements and sleepiness in obstructive sleep apnea patients. Sleep Med 2005; 6(3):225-9.
- Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP. Restless legs syndrome and low brain iron levels in patients with haemochromatosis. J Neurol Neurosurg Psychiatry 2005; 76(7):1009-10.
- Hode Y, Reimold M, Demazières A et al. A positron emission tomography (PET) study of cerebral dopamine D2 and serotonine 5-HT2A receptor occupancy in patients treated with cyamemazine (Tercian). Psychopharmacology 2005; 180(2):377-84.
- Le Bon O, Chabanski S, Dramaix M, Staner L, Pelc I, Linkowski P. Inverse association between Slow Wave Activity per cycle and the number of ultradian sleep cycles per night in healthy humans. Clin Neurophysiol 2005; 116(7):1493-500.
- Monreal JA, Duval F, Mokrani MC, Pinault G, Macher JP. Exploration de la fonction dopaminergique dans les dépressions bipolaires et unipolaires. Ann Med Psychol 2005; 163:399-404.
- Muzet A. Alterations of sleep microstructure in psychiatric disorders. Dialogues in Clinical Neuroscience 2005; 7(4), 315-321.
- Peter JC, Tugler J, Eftekhari P, Maurice D, Hoebeke J, Roegel JC. Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 2005; 19(8):943-9.
- Souery D, Staner L, Zdanowicz N, Floris M, Pitchot W. La dépression bipolaire : la face cachée de l’iceberg. Acta Psychiatrica Belgica 2005 ;105 :131-139.
- Soufflet L, Boeijinga PH. Linear inverse solutions: simulations from a realistic head model in MEG. Brain Topogr 2005; 18(2):87-99.
- Staner L, Ertle S, Boeijinga P et al. Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. Psychopharmacology (Berl) 2005; 181(4):790-8.
- Tremeau F, Malaspina D, Duval F et al. Facial expressiveness in patients with schizophrenia compared to depressed patients and nonpatients comparison subjects. Am J Psychiatry 2005; 162(1):92-101.
- Staner L. Sleep disturbances, psychiatric disorders, and psychotropic drugs. Dialogues in Clinical Neuroscience 2005; 7(4), 323-334.
- Zdanowicz N, Floris M, Pitchot W, Souery D, Staner L. Le déficit de l'attention/hyperactivité (ADHD): la maladie qui fâche. Acta Psychiatrica Belgica, 105, 6-13, 2005.
- Boeijinga PH, Parot P, Soufflet L et al. Pharmacodynamic effects of Acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pretreatment and during alcohol abstinence. Neuropsychobiology 2004; 50(1):71-7.
- Bolo NR, Hode Y, Macher JP. Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivo. MAGMA 2004; 16:268-76.
- Cerf R, Ouasdad el HE, Kahane P. Criticality and synchrony of fluctuations in rhythmical brain activity: pretransitional effects in epileptic patients. Biol Cybern 2004; 90(4):239-55.
- Cornette F, Staner L. La prise en charge non phamracologique de l’insomnie. Acta Psychiatrica Belgica 2004 ;104 :75-84.
- Duval F, Crocq MA, Guillon MS et al. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Psychoneuroendocrinology 2004; 29(10):1281-9.
- Duval F, Crocq MA, Guillon MS et al. Increased adrenocorticotropin suppression following dexamethasone administration in sexually abused adolescents with posttraumatic stress disorder. Ann N Y Acad Sci 2004; 1032:273-5.
- Favrod J, Grasset F, Spreng S, Grossenbacher B, Hode Y. Benevolent Voices Are Not So Kind: The Functional Significance of Auditory Hallucinations. Psychopathology 2004; 37(6):304-8.
- Haba-Rubio J, Staner L, Krieger J, Macher JP. What is the clinical significance of periodic limb movements during sleep? Neurophysiol Clin 2004 Dec;34(6):293-300.
- Jonsson EG, Kaiser R, Brockmoller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr Genet 2004; 14(1):9-12.
- Macher JP, Luthringer R, Staner L. Spectral EEG sleep profiles as a tool for prediction of clinical response to antidepressant treatment. Dialogues Clinical Neuroscience, 6, 78-82, 2004.
- Monreal J, Duval F, Mokrani MC, Pinault G, Atse ML, Macher JP. Multihormonal correlates of personality dimensions in depression. Biol Psychiatry 2004; 55(Suppl 8).
- Peter JC, Wallukat G, Tugler J et al. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments. J Biol Chem 2004; 279(53):55697-706.
- Riban V, Pereira de Vasconcelos A, Pham-Le BT et al. Modifications of local cerebral glucose utilization in thalamic structures following injection of a dopaminergic agonist in the nucleus accumbens--involvement in antiepileptic effects? Exp Neurol 2004; 188(2):452-60.
- Rudolf G, Therese Bihoreau M, F Godfre R et al . Polygenic Control of idiopathic generalized epilepsy phenotypes in the genetic absence rats from Strasbourg (GAERS). Epilepsia 2004; 45(4):301-8.
